Medicines Management Solutions (MMS®) Ltd teams of consultant clinical Pharmacists are renowned for implementation – ensuring improvements of patient outcomes and implementation of cost effective evidence based prescribing. We offer a variety of implementation programs summarised below. If you cannot see what you require please Contact Us for a discussion

MMS Limited Clinical Review Service

We offer a variety of review services to meet the need of the NHS and patients. These can be based around clinical areas or focussed on a cost saving evidence based approach within a practice. Whichever route the reviews are commenced the process and objectives are the same.

Aim to deliver:

  • Improved outcomes for patients
  • More effective, evidence based NHS Prescribing
  • Clinical review by therapy area, locality or by need within a practice
  • Targeted approach in practice (see diagnostics for further information)
    • Cost savings by breakdown including Enteral nutrition, Blood Glucose testing etc
  • Productivity Indices implementation (Statin/PPI/ACE:ARB) – see productivity for further info
  • Care Home Reviews and Accreditation
  • We have already completed the following reviews and have SOP’s and Governance arrangements for reviews:
    • Statins, COPD, Diabetes, Hypertension, PPI, ACE:ARB, SMBG, Enteral Nutrition, Care Home, Mental Health, OAB, CA Prostate, GI, and many more....

Procedure:

Our clinical review process is designed to be flexible to practice needs while maintaining high levels of Governance and a strong Focus on Patients and their needs.

The process comprises:

  • Systematic reviews in specific disease areas
  • Individual patient reviews
  • Audit of the current position
  • Accessing all clinical and therapeutic data
  • Face to face reviews in clinics where required

The review is structured to require a minimal amount of time from practice healthcare professionals;

  • General Practitioner : 1 hour
  • Practice Manager : 30 minutes

Example Outcomes:

The following data demonstrates an example outcome from a Cardiovascular Medicines Management Review. We also have outcomes data from a number of other areas so please Contact Us for further details:

Diabetes (n=84)

  • Mean HbA1c, 7.1% to 6.5%

Hypertension (n=90)

  • Mean BP 151/82 to 135/76

Hyperlipidaemia (n=148)

  • Mean TC 4.6 to 4.3 mmol

Cost Savings - Total £34,300

Diabetes

  • Prescribing £8,100
  • Plus outpatient savings £9,000

Hypertension

  • Prescribing £8,300
  • Plus outpatient savings £8,900

75% ACEi / 25% ARB achieved

HbA1c nGMS target achieved

Process Overview: